رجوع
نطاق اليوم
KWD 13.52
KWD 14.43
نطاق 52 أسبوعًا
KWD 3.11
KWD 17.49
حجم التداول
875,132
متوسط 50 يوم / 200 يوم
KWD 14.34
/
KWD 11.68
الإغلاق السابق
KWD 13.81
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -7.8 | 0.4 |
| P/B | 3.7 | 2.9 |
| ROE % | -61.6 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 22.000
+62.6%
Low: KWD 19.000
High: KWD 28.000
ربحية السهم المستقبلية
-KWD 1.346
الإيرادات المقدّرة
81000
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 2.065
KWD 0.435 – KWD 3.757
|
540 M | 2 |
| FY2029 |
KWD 0.692
KWD 0.146 – KWD 1.258
|
320 M | 4 |
| FY2028 |
-KWD 0.571
-KWD 1.039 – KWD 0.230
|
150 M | 6 |
النقاط الرئيسية
Debt/Equity of 0.02 — conservative balance sheet
Negative free cash flow of -123.48M
PEG of 0.12 suggests growth is underpriced
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)-100.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-61.59%
ROIC-36.94%
Net MarginN/A
Op. MarginN/A
الأمان
Debt / Equity
0.02
Current Ratio14.27
Interest Coverage0.00
التقييم
P/E Ratio
-7.77
P/B Ratio3.68
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -100.00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -144.74M |
| ROE | -61.59% | ROA | -43.51% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -123.48M |
| ROIC | -36.94% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 14.27 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -7.77 | P/B Ratio | 3.68 |
| P/S Ratio | N/A | PEG Ratio | 0.12 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.12B | Enterprise Value | 903.99M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 87.37M | 380.79M | 22.23M | 0.0 |
| Net Income | -144.74M | -301.74M | 49.27M | -198.38M | -87.93M |
| EPS (Diluted) | -1.53 | -4.43 | 0.70 | -2.98 | -1.52 |
| Gross Profit | -525,000.0 | 45.22M | 355.35M | 19.24M | 0.0 |
| Operating Income | -153.29M | -314.73M | 38.80M | -201.34M | -82.69M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 332.65M | 193.63M | 517.45M | 391.45M | 105.61M |
| Total Liabilities | 27.39M | 28.87M | 84.02M | 50.85M | 256.78M |
| Shareholders' Equity | 305.26M | 164.77M | 433.43M | 340.61M | -151.17M |
| Total Debt | 5.96M | 1.98M | 4.24M | 6.28M | 0.0 |
| Cash & Equivalents | 226.65M | 77.39M | 170.20M | 62.53M | 50.19M |
| Current Assets | 323.67M | 189.43M | 464.67M | 382.13M | 104.95M |
| Current Liabilities | 22.69M | 28.41M | 82.04M | 46.61M | 17.40M |